A detailed history of My Legacy Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, My Legacy Advisors, LLC holds 2,918 shares of AMGN stock, worth $817,069. This represents 0.38% of its overall portfolio holdings.

Number of Shares
2,918
Previous 3,444 15.27%
Holding current value
$817,069
Previous $1.08 Million 12.64%
% of portfolio
0.38%
Previous 0.35%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$309.38 - $337.38 $162,733 - $177,461
-526 Reduced 15.27%
2,918 $940,000
Q2 2024

Jul 24, 2024

BUY
$262.75 - $319.31 $136,367 - $165,721
519 Added 17.74%
3,444 $1.08 Million
Q1 2024

Jul 25, 2024

SELL
$268.87 - $324.56 $42,481 - $51,280
-158 Reduced 4.59%
3,286 $934,000
Q4 2023

Jan 12, 2024

BUY
$255.7 - $288.46 $130,407 - $147,114
510 Added 21.12%
2,925 $842,000
Q3 2023

Oct 20, 2023

BUY
$218.65 - $271.46 $528,039 - $655,575
2,415 New
2,415 $649,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track My Legacy Advisors, LLC Portfolio

Follow My Legacy Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of My Legacy Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on My Legacy Advisors, LLC with notifications on news.